NantHealth (NHIQ) Competitors $0.01 +0.00 (+10.00%) As of 07/2/2025 12:30 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NHIQ vs. SYRA, UK, DMSL, MCOM, STBX, CAUD, ASAP, CTK, MULN, and NHShould you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Syra Health (SYRA), Ucommune International (UK), Digital Media Solutions (DMSL), Micromobility.com (MCOM), Starbox Group (STBX), Collective Audience (CAUD), Waitr (ASAP), CooTek (Cayman) (CTK), Mullen Automotive (MULN), and NantHealth (NH). These companies are all part of the "business services" industry. NantHealth vs. Its Competitors Syra Health Ucommune International Digital Media Solutions Micromobility.com Starbox Group Collective Audience Waitr CooTek (Cayman) Mullen Automotive NantHealth Syra Health (NASDAQ:SYRA) and NantHealth (NASDAQ:NHIQ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Is SYRA or NHIQ more profitable? NantHealth has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. NantHealth's return on equity of 0.00% beat Syra Health's return on equity.Company Net Margins Return on Equity Return on Assets Syra Health-54.90% -131.94% -99.19% NantHealth N/A N/A N/A Which has higher valuation & earnings, SYRA or NHIQ? Syra Health has higher earnings, but lower revenue than NantHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSyra Health$7.98M0.14-$2.94M-$0.36-0.27NantHealth$67M0.01-$67.78MN/AN/A Does the media refer more to SYRA or NHIQ? In the previous week, Syra Health had 1 more articles in the media than NantHealth. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for NantHealth. NantHealth's average media sentiment score of 0.00 beat Syra Health's score of -0.53 indicating that NantHealth is being referred to more favorably in the news media. Company Overall Sentiment Syra Health Negative NantHealth Neutral Which has more risk & volatility, SYRA or NHIQ? Syra Health has a beta of 3.85, indicating that its stock price is 285% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 24.76, indicating that its stock price is 2,376% more volatile than the S&P 500. Do institutionals and insiders have more ownership in SYRA or NHIQ? 4.8% of Syra Health shares are owned by institutional investors. 10.2% of Syra Health shares are owned by insiders. Comparatively, 61.3% of NantHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryNantHealth beats Syra Health on 7 of the 11 factors compared between the two stocks. Get NantHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NHIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NHIQ vs. The Competition Export to ExcelMetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$359K$1.13B$5.49B$9.02BDividend YieldN/A3.15%5.38%4.10%P/E RatioN/A4.7927.4720.28Price / Sales0.0118.04408.86121.46Price / CashN/A63.2136.6357.47Price / BookN/A0.978.095.68Net Income-$67.78M-$37.11M$3.17B$248.96M7 Day PerformanceN/A-0.17%2.81%3.30%1 Month PerformanceN/A2.96%3.67%5.20%1 Year PerformanceN/A-1.27%35.41%21.37% NantHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHIQNantHealthN/A$0.01+10.0%N/AN/A$359K$67M0.00340High Trading VolumeSYRASyra Health0.2226 of 5 stars$0.10-13.3%N/A-92.6%$1.18M$7.98M-0.1678Gap DownUKUcommune InternationalN/A$1.03-1.8%N/A-46.6%$649K$23.92M0.00510Positive NewsDMSLDigital Media SolutionsN/AN/AN/AN/A$483K$334.95M0.00580MCOMMicromobility.comN/A$0.01+6.4%N/A-55.0%$461K$13.16M0.00360STBXStarbox GroupN/A$1.90-18.3%N/A-99.5%$404K$6.17M0.00103High Trading VolumeCAUDCollective AudienceN/A$0.01+270.0%N/A-95.9%$264K$12.14M0.0023Upcoming EarningsASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840CTKCooTek (Cayman)N/A$0.03-22.5%N/A+362.7%$231K$30.32M0.00380High Trading VolumeMULNMullen AutomotiveN/A$0.29-4.5%N/A-100.0%$129K$1.09M0.00120High Trading VolumeNHNantHealthN/A$0.01flatN/AN/A$85K$67.68M0.00340Gap Up Related Companies and Tools Related Companies SYRA Alternatives UK Alternatives DMSL Alternatives MCOM Alternatives STBX Alternatives CAUD Alternatives ASAP Alternatives CTK Alternatives MULN Alternatives NH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NHIQ) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.